Chen Suning
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia (NCT06746519) | Chen Suning | 2024-12-25 |
| The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCT (NCT05675826) | Chen Suning | 2022-12-26 |
| A Study of Olverembatinib in the Treatment of Ph+ ALL (NCT05466175) | Chen Suning | 2022-10-01 |
| Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL (NCT05557110) | Chen Suning | 2022-09-08 |
| Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML (NCT05177731) | Chen Suning | 2022-03-01 |
Track Chen Suning automatically
Every clearance here is in the API, with alerts when new ones post.